Leflunomide as a cause of collagenous colitis: An entity to consider

Simple item page
dc.coverageDOI: 10.17235/reed.2021.8015/2021
dc.creatorNúñez, Paulina
dc.creatorQuera, Rodrigo
dc.creatorFlores, Lilian
dc.creatorContreras, Luis
dc.date2021
dc.date.accessioned2026-01-05T21:12:36Z
dc.date.available2026-01-05T21:12:36Z
dc.description<p>Leflunomide belongs in the group of disease-modifying anti-rheumatic drugs (DMARDs) used in the treatment of psoriatic, rheumatoid, and reactive arthritis. Approximately 20 % of patients will experience some adverse event, mainly weight loss, abdominal pain, and diarrhea. We describe the clinical, endoscopic, and histological findings in a patient with psoriatic arthritis (PA) who developed severe chronic diarrhea after drug use.</p>eng
dc.descriptionLeflunomide belongs in the group of disease-modifying anti-rheumatic drugs (DMARDs) used in the treatment of psoriatic, rheumatoid, and reactive arthritis. Approximately 20 % of patients will experience some adverse event, mainly weight loss, abdominal pain, and diarrhea. We describe the clinical, endoscopic, and histological findings in a patient with psoriatic arthritis (PA) who developed severe chronic diarrhea after drug use.spa
dc.identifierhttps://investigadores.uandes.cl/en/publications/c5b1dfb8-1ab8-4a44-8c83-c3b035a215c0
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/65321
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.113 (2021) nr.10 p.735-736
dc.subjectChronic diarrhea
dc.subjectCollagenous colitis
dc.subjectLeflunomide
dc.subjectLeflunomide
dc.subjectCollagenous colitis
dc.subjectSDG 3 - Good Health and Well-being
dc.titleLeflunomide as a cause of collagenous colitis: An entity to considereng
dc.typeLettereng
dc.typeCartaspa
Files
Collections
Pure-CRIS